Clinical Trials Browser

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06211413 2025-03-18

SENTINEL

Enrolling by invitation

50 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

NCT04488354 2025-01-10

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Phase 1 Enrolling by invitation

36 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

60 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

PERSIST

Watch and Wait or Worry and Wait in Indolent Lymphoma

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

SENTINEL

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

VTB-CLL002